Cardinal Health Inc. ($CAH) Stock Forecast: Down 7.3% Today

What is Cardinal Health Inc.?

Cardinal Health (CAH) is a healthcare services and products company listed on the NYSE. It operates in the medical and pharmaceutical sectors, providing a range of services to healthcare providers.

Why is Cardinal Health Inc. going down?

CAH stock is down 7.3% on Aug 12, 2025 16:40

• There has been bullish options activity indicating positive sentiment from investors, although this did not result in a positive stock movement.
• The company exceeded earnings estimates and raised EPS guidance for 2026, leading to a stock drop potentially linked to concerns about the expiration of the OptumRx contract and its impact on Pharmaceutical segment sales.
• The upcoming release of Q4 earnings may have caused stock price volatility as investors reacted to forecast changes and dividend income strategies.
• A comparison with Adaptive Biotechnologies in the medical sector suggests that market dynamics and company-specific factors could have influenced Cardinal Health's bearish performance despite positive developments.

CAH Price Chart

CAH Technical Analysis

CAH News

Decoding Cardinal Health's Options Activity: What's the Big Picture? - Cardinal Health ( NYSE:CAH )

Whales with a lot of money to spend have taken a noticeably bullish stance on Cardinal Health. Looking at options history for Cardinal Health CAH we detected 25 trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish ...

https://www.benzinga.com/insights/options/25/08/47063037/decoding-cardinal-healths-options-activity-whats-the-big-picture

CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls

Cardinal Health's fourth-quarter fiscal 2025 results benefit from solid Medical and Other segments' revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.

https://www.zacks.com/stock/news/2702503/cah-q4-earnings-beat-estimates-26-eps-view-up-stock-falls

Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Cardinal Health ( NYSE:CAH )

Cardinal Health, Inc. CAH will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug. 12. Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the year-ago period.

https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47049141/cardinal-health-gears-up-for-q4-print-here-are-the-recent-forecast-changes-fro

How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings - Cardinal Health ( NYSE:CAH )

A more conservative goal of $100 monthly dividend income would require 587 shares of Cardinal Health. An investor would need to own $462,313 worth of Cardinal Health to generate a monthly dividend income of $500. The next 100%+ earnings move could hit this month. See how to find it live on ...

https://www.benzinga.com/trading-ideas/dividends/25/08/47031907/how-to-earn-500-a-month-from-cardinal-health-stock-ahead-of-q4-earnings-2

Has Adaptive Biotechnologies ( ADPT ) Outpaced Other Medical Stocks This Year?

Here is how Adaptive Biotechnologies (ADPT) and Cardinal Health (CAH) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2683925/has-adaptive-biotechnologies-adpt-outpaced-other-medical-stocks-this-year

Trending Today

Chainlink ($LINK) Crypto Forecast: Down 5.4% Today

First Solar Inc. ($FSLR) Stock Forecast: Down 7.0% Today

Novavax Inc. ($NVAX) Stock Forecast: Down 12.2% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 9.5% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Down 5.0% Today

Credo Technology Group ($CRDO) Stock Forecast: Up 6.3% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 6.1% Today

Etsy Inc. ($ETSY) Stock Forecast: Down 5.1% Today

Pacific Gas & Electric Co. ($PCG) Stock Forecast: Down 5.1% Today

Coty Inc. Class A ($COTY) Stock Forecast: Down 22.0% Today

Cardinal Health Inc. Price History

01.10.2024 - CAH Stock was up 6.4%

• In the first quarter of 2025, Cardinal Health (CAH) posted strong results, surpassing adjusted EPS expectations and outperforming sales consensus. The success was mainly attributed to the robust performance of its drug distribution business.
• By revising its profit outlook for 2025 upwards, the company demonstrates confidence in its growth path and ability to seize opportunities within the healthcare industry.
• Following the impressive earnings announcement, the market reacted positively to Cardinal Health, resulting in a bullish trend in the stock price. Investors appreciated the company's solid financial performance and strategic efforts to navigate supply chain obstacles.

01.10.2024 - CAH Stock was up 6.3%

• Cardinal Health (CAH) experienced a strong bullish movement today following its Q1 earnings report:
• The company beat expectations with first-quarter fiscal 2025 results, driven by solid growth in Pharmaceutical and Specialty Solutions.
• Despite a decrease in sales due to the OptumRx contract expiry, the raised earnings per share (EPS) outlook for 2025 boosted investor confidence.
• The positive market reaction can be attributed to:
• Strong performance in the drug distribution business, leading to an increase in adjusted operating earnings.
• Continued growth prospects supported by new facilities, acquisitions, and overcoming supply chain challenges.
• The market's focus on CAH's robust financial performance overshadowed concerns about sector comparisons and potential competition from other medical stocks like Atossa Genetics (ATOS).
• Overall, Cardinal Health's resilience and strategic initiatives in the healthcare sector have positioned the company favorably, driving investor optimism and contributing to today's bullish market movement.

31.00.2025 - CAH Stock was down 5.4%

• CAH reported strong Q2 earnings and sales that exceeded expectations, with an increase in the 2025 EPS view. Still, the negative impact of the OptumRx contract expiry on Pharmaceutical segment sales likely contributed to the bearish movement.
• The news of a Congress member buying up to $15K in Cardinal Health stock may have added some uncertainty or negative sentiment to the market, influencing the stock's downward trend.
• Despite solid revenue growth in the Other segment and increased sales in branded and specialty pharmaceuticals, concerns about the OptumRx contract expiry and supply-chain challenges may have overshadowed positive developments.
• Investors may approach Cardinal Health cautiously due to recent events and uncertainties surrounding the company's key segments and contracts.

06.00.2025 - CAH Stock was down 1.3%

• Despite CAH's strong quarterly results and robust product portfolio, the stock experienced a -1.02% decline in the most recent trading session.
• The market movement could be attributed to profit-taking by investors after a period of growth, leading to a temporary dip in the stock price.
• Investors might be reacting to broader market trends or sector-specific news impacting healthcare companies, causing a negative sentiment towards CAH in today's trading.

30.00.2025 - CAH Stock was up 0.0%

• The positive anticipation surrounding its upcoming Q2 earnings report, with growth in branded and specialty pharmaceutical sales expected to drive performance, could be a factor in the recent bullish movement in CAH.
• Market sentiment might have been influenced by a Congress member's purchase of Cardinal Health stock, signaling confidence in the company's future prospects.
• Contributing to the upward momentum in CAH's stock price could be the overall bullish trend in the market and the company hitting a 52-week high.

04.03.2025 - CAH Stock was down 5.6%

• CAH stock fell by 1.14% in the latest trading session.
• This downward movement could be related to market volatility or negative factors affecting the healthcare industry.
• Investors may be responding to worries about regulatory adjustments or changes in consumer healthcare demands.
• Traders should stay updated on company-specific updates and broader market patterns when considering CAH's stock.

11.11.2024 - CAH Stock was down 1.4%

• The strength in CAH's pharmaceutical segment and diversified product portfolio was not enough to counterbalance the challenges of concentrated revenue generation and regulatory setbacks.
• Concerns about concentrated revenue generation and regulatory setbacks seemed to heavily influence investor sentiment, causing a decline in CAH's stock.
• Despite the positive aspects of the company's business segments, challenges mentioned earlier seemed to overshadow potential gains, resulting in today's bearish market movement for CAH.

12.07.2025 - CAH Stock was down 7.3%

• There has been bullish options activity indicating positive sentiment from investors, although this did not result in a positive stock movement.
• The company exceeded earnings estimates and raised EPS guidance for 2026, leading to a stock drop potentially linked to concerns about the expiration of the OptumRx contract and its impact on Pharmaceutical segment sales.
• The upcoming release of Q4 earnings may have caused stock price volatility as investors reacted to forecast changes and dividend income strategies.
• A comparison with Adaptive Biotechnologies in the medical sector suggests that market dynamics and company-specific factors could have influenced Cardinal Health's bearish performance despite positive developments.

12.07.2025 - CAH Stock was down 12.2%

• The bearish movement in CAH stock could be attributed to investors' concerns about the upcoming earnings report falling short of expectations.
• Discussion about earning $500 a month from CAH stock might have raised unrealistic expectations among investors, leading to disappointment when the stock did not perform as anticipated.
• A comparison with Adaptive Biotechnologies (ADPT) might have highlighted stronger performance in the medical sector by ADPT, causing some investors to shift their focus away from CAH.
• Overall, the bearish movement in CAH could be a result of a combination of profit-taking, cautious investor sentiment ahead of the earnings report, and comparative underperformance within the sector.

14.07.2024 - CAH Stock was up 5.1%

• Cardinal Health Inc.'s stock experienced a strong bullish movement today.
• The surprising 11% stock rally can be attributed to the company exceeding fourth-quarter earnings and revenue estimates, driven by strong sales of pharmaceuticals.
• The positive earnings report, where Cardinal Health beat EPS and revenue expectations, along with raising its EPS guidance for fiscal 2024, likely fueled investor optimism and contributed to the bullish market movement.
• The market's positive reaction indicates investor confidence in Cardinal Health's financial performance and outlook, positioning the company favorably in the healthcare services sector.

14.07.2024 - CAH Stock was up 5.9%

• Cardinal Health (CAH) surpassed expectations on Q4 earnings and raised its EPS guidance for fiscal 2024, showcasing solid profit growth in Pharmaceutical and Specialty Solutions.
• The robust Q4 results and raised outlook contributed to the positive market sentiment towards CAH stock.
• The strong performance of Cardinal Health overshadowed concerns in the healthcare sector, as indicated by the warning of potential crashes in other health care stocks.
• Overall, the optimistic outlook and financial performance of Cardinal Health drove the bullish movement in its stock, demonstrating investor confidence in the company's future prospects.

10.05.2025 - CAH Stock was down 0.5%

• The overall market sentiment is bearish today.
• The bearish movement in CAH stock could be attributed to the announcement of a distribution services agreement between Citius Pharmaceuticals and Cardinal Health. This partnership might have raised concerns among investors about potential competition or changes in Cardinal Health's business strategy, leading to a negative impact on CAH stock price.